{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:50:51Z","timestamp":1757451051998,"version":"3.40.4"},"reference-count":38,"publisher":"University of Tokushima Faculty of Medicine","issue":"1.2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2025]]},"DOI":"10.2152\/jmi.72.34","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T22:06:55Z","timestamp":1745359615000},"page":"34-41","source":"Crossref","is-referenced-by-count":1,"title":["Lipolysis-stimulated lipoprotein receptor is involved in fatty acid binding protein 4-mediated prostate cancer cell growth in bone"],"prefix":"10.2152","volume":"72","author":[{"given":"Tetsuyuki","family":"Takahashi","sequence":"first","affiliation":[{"name":"Department of Anatomy and Cell Biology, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Tsunematsu","sequence":"additional","affiliation":[{"name":"Department of Oral Molecular Pathology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisanori","family":"Uehara","sequence":"additional","affiliation":[{"name":"Division of Pathology, Tokushima University Hospital, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Fowke JH, Motley SS, Concepcion RS, Penson DF, Barocas DA : Obesity, body composition, and prostate cancer. BMC Cancer 12 : 23, 2012","DOI":"10.1186\/1471-2407-12-23"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rundle A, Jankowski M, Kryvenko ON, Tang D, Rybicki BA : Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate. Cancer Epidemiol Biomarkers Prev 22 : 898-904, 2013","DOI":"10.1158\/1055-9965.EPI-12-0965"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rivera-Izquierdo M, P\u00e9rez de Rojas J, Mart\u00ednez-Ruiz V, P\u00e9rez-G\u00f3mez B, S\u00e1nchez MJ, Khan KS, Jim\u00e9nez-Mole\u00f3n JJ : Obesity as a risk factor for prostate cancer mortality : A systematic review and dose-response meta-analysis of 280,199 patients. Cancers 13 : 4169, 2021","DOI":"10.3390\/cancers13164169"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Onuma M, Bub JD, Rummel TL, Iwamoto Y : Prostate cancer cell-adipocyte interaction : leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J Biol Chem 278 : 42660-42667, 2003","DOI":"10.1074\/jbc.M304984200"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Okamoto M, Lee C, Oyasu R : Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res 57 : 141-146, 1997","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<149::AID-IJC21>3.0.CO;2-D"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bennett JL, Jackson BN, Miller RJ, Tsui H, Mertin-Caraballo M : IL-6 evoked biochemical changes in prostate cancer cells. Cytokine 161 : 156079, 2023","DOI":"10.1016\/j.cyto.2022.156079"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wang X, Yang L, Huang F, Zhang Q, Liu S, Ma L, You Z : Inflammatory cytokines IL-17 and TNF-\u03b1 upregulate PD-L1 expression in human prostate and colon cancer cells. Immunol Lett 184 : 7-14, 2017","DOI":"10.1016\/j.imlet.2017.02.006"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cerezo LA, Kuklov\u00e1 M, Hukejov\u00e1 H, Vernerov\u00e1 Z, Pe\u0161\u00e1kov\u00e1 V, Pecha O, Veigl D, Haluz\u00edk M, Pavelka K, Vencovsk\u0177 J, Senolt L : The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels. Cytokine 64 : 441-447, 2013","DOI":"10.1016\/j.cyto.2013.05.001"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM : Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274 : 1377-1379, 1996","DOI":"10.1126\/science.274.5291.1377"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Djouss\u00e9 L, Gaziano JM : Plasma levels of FABP4, but not FABP3, are associated with increased risk of diabetes. Lipids 47 : 757-762, 2012","DOI":"10.1007\/s11745-012-3689-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gormez S, Erdim R, Akan G, Caynak B, Duran C, Gunay D, Sozer V, Atalar F : Relationships between visceral \/ subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome. Cardiovasc Pathol 46 : 107192, 2020","DOI":"10.1016\/j.carpath.2019.107192"},{"key":"12","unstructured":"12. De Santis ML, Hammamieh R, Das R, Jett M : Adipocyte-fatty acid binding protein induces apoptosis in DU145 prostate cancer cells. J Exp Ther Oncol 4 : 91-100, 2004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Harjes U, Bridges E, Gharpure KM, Roxanis I, Sheldon H, Miranda F, Mangala LS, Pradeep S, Lopez-Berestein G, Ahmed A, Fielding B, Sood AK, Harris AL : Antiangiogenic and tumor inhibitory effects of downregulating tumour endothelial FABP4. Oncogene 36 : 912-921, 2017","DOI":"10.1038\/onc.2016.256"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wu Z, Jeong JH, Ren C, Yang L, Ding L, Li F, Jiang D, Zhu Y, Lu J : Fatty acid-binding protein 4 (FABP4) suppresses proliferation and migration of endometrial cancer cells via PI3K \/ Akt pathway. Onco Targets Ther 14 : 3929-3942, 2021","DOI":"10.2147\/OTT.S311792"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, Yamada SD, Peter ME, Gwin K, Lengyel E : Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17 : 1498-1503, 2011","DOI":"10.1038\/nm.2492"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mukherjee A, Chiang CY, Daifotis HA, Nieman KM, Fahrmann JF, Lastra RR, Romero I, Fiehn O, Lengyel E : Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance. Cancer Res 80 : 1748-1761, 2020","DOI":"10.1158\/0008-5472.CAN-19-1999"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yang J, Liu S, Li Y, Fan Z, Meng Y, Zhou B, Zhang G, Zhan H : FABP4 in macrophages facilitates obesity-associated pancreatic cancer progression via NLRP3 \/ IL-1\u03b2 axis. Cancer Lett 575 : 216403, 2023","DOI":"10.1016\/j.canlet.2023.216403"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Uehara H, Takahashi T, Oha M, Ogawa H, Izumi K : Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression. Int J Cancer 135 : 2558-2568, 2014","DOI":"10.1002\/ijc.28903"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Takahashi T, Uehara H, Bando Y, Izumi K : Soluble EP2 neutralizes prostaglandin E2-induced cell signaling and inhibits osteolytic tumor growth. Mol Cancer Ther 7 : 2807-2816, 2008","DOI":"10.1158\/1535-7163.MCT-08-0153"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Uehara H, Kim SJ, Karashima T, Shepherd DL, Fan D, Tsan R, Killion JJ, Logothetis C, Mathew P, Fidler IJ : Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastasis. J Natl Cancer Inst 95 : 458-470, 2003","DOI":"10.1093\/jnci\/95.6.458"},{"key":"21","unstructured":"21. Nemeth JA, Harb JF, Barroso Jr U, He Z, Grignon DJ, Cher ML : Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 59 : 1987-1993, 1999"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. himada H, Kohno T, Konno T, Okada T, Saito K, Shindo Y, Kikuchi S, Tsujiwaki M, Ogawa M, Matsuura M, Saito T, Kojima T : The roles of tricellular tight junction protein Angulin-1 \/ Lipolysis-stimulated lipoprotein receptor (LSR) in endometriosis and endometrioid-endometrial carcinoma. Cancers 13 : 6341, 2021","DOI":"10.3390\/cancers13246341"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Herbsleb M, Birkenkamp-Demtroder K, Thykjaer T, Wiuf C, Hein AMK, Orntoft TF, Dyrskj\u00f8t L : Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells. BMC Med Genomics 1 : 31, 2008","DOI":"10.1186\/1755-8794-1-31"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Czulkies BA, Mastroianni J, Lutz L, Lang S, Schwan C, Schmidt G, Lassmann S, Zeiser R, Aktories K, Papatheodorou P : Loss of LSR affects epithelial barrier integrity and tumor xenograft growth of CaCo-2 cells. Oncotarget 8 : 37009-37022, 2017","DOI":"10.18632\/oncotarget.10425"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kyuno T, Kyuno D, Kohno T, Konno T, Kikuchi S, Arimoto C, Yamaguchi H, Imamura M, Kimura Y, Kondoh M, Takemasa I, Kojima T : Tricellular tight junction protein LSR \/ angulin-1 contributes to the epithelial barrier and malignancy in human pancreatic cancer cell line. Histochem Cell Biol 153 : 5-16, 2020","DOI":"10.1007\/s00418-019-01821-4"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Reaves DK, Fagan-Solis KD, Dunphy K, Oliver SD, Scott DW, Fleming JM : The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior. PLos One 9 : e91747, 2014","DOI":"10.1371\/journal.pone.0091747"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Takahashi Y, Serada S, Ohkawara T, Fujimoto M, Hiramatsu K, Ueda Y, Kimura T, Takemori H, Naka T : LSR promotes epithelial ovarian cancer cell survival under energy stress through the LKB1-AMPK pathway. Biochem Biophys Res Commun 537 : 93-99, 2021","DOI":"10.1016\/j.bbrc.2020.12.079"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Parsana P, Amend SR, Hernandez J, Pienta KJ, Battle A : Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multistudy integration. BMC Cancer 17 : 447, 2017","DOI":"10.1186\/s12885-017-3413-3"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Schlessinger J : Allosteric regulation of the epidermal growth factor receptor kinase. J Cell Biol 103 : 2067-2072, 1986","DOI":"10.1083\/jcb.103.6.2067"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Goh LK, Sorkin A : Endocytosis of receptor tyrosine kinases. Cold Spring Harb Perspect Biol 5 : a017459, 2013","DOI":"10.1101\/cshperspect.a017459"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Nagahama M, Takehara M, Seike S, Sakaguchi Y : Cellular uptake and cytotoxicity of <i>Clostridium perfringens<\/i> Iota-toxin. Toxins 15 : 695, 2023","DOI":"10.3390\/toxins15120695"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Sugase T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hiramatsu K, Koh M, Saito Y, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Hanazaki K, Mori M, Doki Y, Naka T : Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer. Oncotarget 9 : 32917-32928, 2018","DOI":"10.18632\/oncotarget.25952"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Esposito M, Guise T, Kang Y : The biology of bone metastasis. Cold Spring Harb Perspect Med 8 : a031252, 2018","DOI":"10.1101\/cshperspect.a031252"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Hensel J, Wetterwald A, Temanni R, Keller I, Riether C, van der Pluijm G, Cecchini MG, Thalmann GN : Osteolytic cancer cells induce vascular \/ axon guidance processes in the bone \/ bone marrow stroma. Oncotarget 9 : 28877-28896, 2018","DOI":"10.18632\/oncotarget.25608"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Arellano DL, Ju\u00e1rez P, Verdugo-Meza A, Almeida-Luna PS, Corral-Avila JA, Drescher F, Olvera F, Jimen\u00e9z S, Elzey BD, Guise TA, Fournier PGJ : Bone microenvironment-suppressed T cells increase osteoclast formation and osteolytic bone metastasis in mice. J Bone Miner Res 37 : 1446-1463, 2022","DOI":"10.1002\/jbmr.4615"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Shiirevnyamba A, Takahashi T, Shan H, Ogawa H, Yano S, Kanayama H, Izumi K, Uehara H : Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts. Br J Cancer 104 : 505-513, 2011","DOI":"10.1038\/sj.bjc.6606070"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Nagase Y, Hiramatsu K, Funauchi M, Shiomi M, Masuda T, Kakuda M, Nakagawa S, Miyoshi A, Matsuzaki S, Kobayashi E, Kimura T, Serada S, Ueda Y, Naka T, Kimura T : Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer. BMC Cancer 22 : 679, 2022","DOI":"10.1186\/s12885-022-09789-6"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kanda M, Serada S, Hiramatsu K, Funauchi M, Obata K, Nakagawa S, Ohkawara T, Murata O, Fujimoto M, Chiwaki F, Sasaki H, Ueda Y, Kimura T, Naka T : Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer. Neoplasia 35 : 100853, 2023","DOI":"10.1016\/j.neo.2022.100853"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/72\/1.2\/72_34\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T04:47:47Z","timestamp":1745642867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/72\/1.2\/72_34\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":38,"journal-issue":{"issue":"1.2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.72.34","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"type":"print","value":"1343-1420"},{"type":"electronic","value":"1349-6867"}],"subject":[],"published":{"date-parts":[[2025]]}}}